Research Analysts’ Recent Ratings Changes for Doximity (DOCS)

A number of research firms have changed their ratings and price targets for Doximity (NYSE: DOCS):

• 4/20/2026 – Doximity had its “hold” rating reaffirmed by Truist Financial Corporation. They now have a $29.00 price target on the stock, down from $37.00.
• 4/16/2026 – Doximity had its price target lowered by Bank of America Corporation from $56.00 to $47.00. They now have a “buy” rating on the stock.
• 4/13/2026 – Doximity had its price target lowered by KeyCorp from $38.00 to $30.00. They now have an “overweight” rating on the stock.
• 4/9/2026 – Doximity had its price target lowered by The Goldman Sachs Group, Inc. from $34.00 to $28.00. They now have a “neutral” rating on the stock.
• 4/8/2026 – Doximity was downgraded by Evercore Inc from “outperform” to “in-line”. They now have a $25.00 price target on the stock.
• 4/6/2026 – Doximity was downgraded by Zacks Research from “hold” to “strong sell”.
• 3/17/2026 – Doximity was given a new $31.00 price target by Loop Capital.
• 3/17/2026 – Doximity was upgraded by Freedom Capital to “strong-buy”.
• 3/9/2026 – Doximity had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $44.00 price target on the stock.
• 2/20/2026 – Doximity had its price target lowered by JPMorgan Chase & Co. from $40.00 to $33.00. They now have a “neutral” rating on the stock.
• 2/20/2026 – Doximity had its price target raised by Piper Sandler from $40.00 to $42.00. They now have an “overweight” rating on the stock.

Insider Transactions at Doximity

In other Doximity news, insider Siddharth Sitaram sold 2,427 shares of the company’s stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $21.09, for a total value of $51,185.43. Following the transaction, the insider directly owned 86,705 shares in the company, valued at $1,828,608.45. This represents a 2.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction dated Tuesday, March 3rd. The stock was sold at an average price of $26.00, for a total transaction of $52,000.00. Following the completion of the transaction, the director owned 19,839 shares in the company, valued at $515,814. This represents a 9.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 9,028 shares of company stock worth $225,641 over the last 90 days. Insiders own 31.30% of the company’s stock.

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.